Recruiting

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(23 sites)

United States

Antelope Valley Clinical Trials, Lancaster, California

UCLA Division of Dermatology, Los Angeles, California

Renstar Medical Research, Ocala, Florida

Palm Harbor Dermatology PA d/b/a TrueBlue Clinical Research, Tampa, Florida

Arlington Dermatology, Rolling Meadows, Illinois

Forest Hills Dermatology Group, Kew Gardens, New York

Inmagene Site 1, New York, New York

Vitality Clinical Trials LLC, Woodbury, New York

Darst Dermatology, Charlotte, North Carolina

Red River Research Partners, LLC, Fargo, North Dakota

ClinOhio Research Services LLC., Columbus, Ohio

Apex Clinical Research Center, Mayfield Heights, Ohio

Oregon Dermatology and Research Center, Portland, Oregon

Palmetto Clinical Trial Services, LLC, Anderson, South Carolina

Stryde Research-Epiphany Dermatology, Southlake, Texas

Dermatology of Seattle & Bellevue, Burien, Washington

Canada

Dr. Chin-ho-Hong Medical Inc., Surrey, British Columbia

PacificDerm, Vancouver, British Columbia

Sudbury Skin Clinique, Greater Sudbury, Ontario

DermEdge Research, Mississauga, Ontario

North Bay Dermatology Centre, North Bay, Ontario

Innovaderm Research Inc., Montreal, Quebec

Skinsense Medical Research, Saskatoon, Saskatchewan